Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04036188
EARLY_PHASE1

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

Sponsor: Wright State University

View on ClinicalTrials.gov

Summary

These studies are designed to assess the synergistic efficacy of topical 0.1% triamcinolone cream paired with 40,000 IU of oral vitamin D3 daily in treating mild to moderate psoriasis. The study is designed to have all subjects treated with triamcinolone cream (TAC) for 4 weeks, then will be randomized 1:1 into vitamin D3 or placebo for an additional 12 weeks. At that time, the study will become open-label and all subjects will be placed on (or continue) vitamin D3 for an additional 12 weeks. The study will take place over 28 weeks total.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2019-10-16

Completion Date

2026-12

Last Updated

2026-02-19

Healthy Volunteers

No

Interventions

DRUG

Triamcinolone

Triamcinolone 0.1% daily

DIETARY_SUPPLEMENT

Vitamin D3

40,000 IU Vitamin D3 daily

DRUG

Placebo

Placebo daily

Locations (1)

Wright State Physicians

Fairborn, Ohio, United States